Global University Venturing

Duke University will launch its Research Translation and Commercialization effort in July to expand its capacity to generate more spinouts and accelerate discoveries.

Weizmann Institute of Science participated in a series B round for its spinout that was originally known as OnSight Medical.

Kyoto University and University of Tokyo both participated in a series B round for the artwork-focused blockchain technology developer.

Appia Bio has emerged from stealth with $52m in series A financing to commercialise cancer treatments based on research at UCLA.

Atlantic Bridge has launched the University Bridge Fund II, with University College Cork joining existing partners Trinity College Dublin and University College Dublin.

MIT spinout Ginkgo Bioworks will go public through a reverse merger with Soaring Eagle Acquisition Corp to list on the Nasdaq Capital Market.

AbbVie subsidiary Allergan Aesthetics has agreed to acquire Soliton, which is commercialising a cellulite treatment based on research at University of Texas.

The venture fund, focused on companies out of MIT, Harvard and Rochester, has collected more than $191m on its way to a $325m target.

UChicago once again invested in Kin Insurance, participating in a $63.9m series C round that brought its overall funding to nearly $150m.

Cambridge’s gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.

The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.